Abstract
Diabetes insipidus (DI) is a syndrome characterized by the excretion of abnormally large volumes of dilute urine. The polyuria causes symptoms of urinary frequency and nocturia and sometimes, incontinence and enuresis. It is also associated with thirst and/or a commensurate increase in fluid intake (polydipsia).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Robertson GL. Diabetes insipidus. Endocrinol Metab Clin North Am 1995; 24: 549–572.
Hansen LK, Rittig S, Robertson GL. Genetic basis of familial neurohypophyseal diabetes insipidus. TEM 1997; 8: 363–372.
Durr JA. Diabetes insipidus in pregnancy. Am J Kidney Dis 1987; 9: 276–283.
Knoers N, Monnens LAH. Nephrogenic diabetes insipidus: clinical symptoms, pathogenesis, genetics and treatment (invited review). Pediatr Nephrol 1992; 6: 476–482.
Robertson GL. Dipsogenic Diabetes insipidus: a newly recognized syndrome caused by a selective defect in the osmoregulation of thirst. Trans Assoc Physician 1987; 100: 241–249.
Illowsky BP, Kirch DG. Polydipsia and hyponatremia in psychiatric patients. Am J Psychiatry 1988; 145: 675–683.
Goldman MB, Luchins DJ, Robertson GL. Mechanisms of altered water metabolism in psychotic patients with polydipsia and hyponatremia. N Engl J Med 1988; 318: 397–403.
Zimmerman EA, Ma LY, Nilaver G. Anatomical basis of thirst and vasopressin secretion. Kidney Int 1987; 32 (suppl 21): S14 - S19.
Schmale H, Fehr S, Richter D. Vasopressin biosynthesis-from gene to peptide hormone. Kidney Int 1987; 32 (suppl 21): S8 - S13.
Knepper MA, Wade JB, Terris J, et al. Renal aquaporins. Kidney Int 1996; 49: 1712–1717.
Nielsen S, Marples D, Frokiaer J, et al. The aquaporin family of water channels in kidney: an update on physiology and pathophysiology of aquaporin-2. Kidney Int 1996; 49: 1718–1723.
Mannucci PM. Desmopressin: a nontransfusional form of treatment for congenital and acquired bleeding disorders. Blood 1988; 72: 1449–1455.
Zerbe RL, Robertson GL. Osmotic and nonosmotic regulation of thirst and vasopressin secretion. In: Narins RG, ed. Clinical disorders of fluid and electrolyte metabolism. McGraw Hill, New York, NY, 1994, pp. 81–100.
Robertson GL. Differential diagnosis of polyuria. Ann Rev Med 1988; 39: 425–442.
Elster AD. Modern imaging of the pituitary. Radiology 1993; 187: 1–14.
Richardson DW, Robinson AG. Desmopressin. Ann Intern Med 1985; 103: 228–239.
Fjellstad-Paulsen A, Paulsen O, d’Agay-Abensour L, Lundin S, Czernichow P. Central diabetes insipidus:oral treatment with dDAVP. Reg Pep 1993; 45: 303–307.
Lam KS, Wat MS, Choi KL, Ip TP, Pang RWC, Kumana CR. Pharmacokinetics, pharmacodynamics, long-term efficacy and safety of oral 1-deamino-8-D-arginie vasopressin in adult patients with central diabetes insipidus. Br J Clin Pharm 1996; 42: 379–385.
Robertson GL. Posterior pituitary. In: Felig P, Baxter JD, Frohman LA, eds. Endocrinology and Metabolism, 3rd ed. McGraw Hill, New York, 1995, pp. 385–432.
Byun KY, Gaskill MB, Robertson GL. The mechanism of chlorpropamide antidiuresis in diabetes insipidus. Clin Res 1984;32:483 A.
Moses AM, Numann P, Miller M. Mechanism of chlorpropamide-induced antidiuresis in man: evidence for release of ADH and enchancement of peripheral action. Metabolism 1973; 22: 59–66.
Moses AM, Howanitz J, van Gemert M, Miller M. Clofibrate-induced antidiuresis. J Clin Invest (1973) 52: 535–542.
Thompson P Jr, Earll JM, Schaaf M. Comparison of clofibrate and chlorpropamide in vasopressinresponsive diabetes insipidus. Metabolism 1977; 26: 749–762.
Van Amelsvoort T, Bakshi R, Devaux CB, Schwabe S. Hyponatremia associated with carbamazepine and oxacarbazepine therapy: a review. Epilepsia 1994; 35: 181–188.
Stephens WP, Coe JY, Baylis PH. Plasma arginine vasopressin concentration and antidiuretic action of carbamazepine. Br Med J 1978; 1: 1445–1447.
Gold PW, Robertson GL, Ballenger JC, et al. Carbamazepine diminishes the sensitivity of the plasma arginine vasopressin response to osmotic stimulation. J Clin Endocrinol Metab 1983; 57: 952–957.
Friedman E, Shadel M, Halkin H, Farfel Z. Thiazide-induced hyponatremia: Reproducibility by single dose rechalenge and an analysis of pathogenesis. Ann Intern Med 1989; 110: 24–30.
Walter SJ, Skinner J, Laycock JF, et al. The antidiuretic effect of chronic hydrochlorothiazide treatment in rats with diabetes insipidus: Water and electrolyte balance. Clin Sci 1982; 63: 525–532.
Shirley DG, Walter SJ, Laycock JF. The antidiuretic effect of chronic hydrochlorothiazide treatment in rats with diabetes insipidus: renal mechanisms. Clin Sci 1982; 63: 533–538.
Seckl JR, Dunger DB. Postoperative DI. Br Med J 1989; 298: 2–3.
Ciric I, Ragin A, Baumgartner C, Pierce D. Complications of transsphenoidal surgery: results of a national survey, review of the literature and personal experience. Neurosurgery 1997; 40: 225–236.
Seckl JR, Dunger DB. Neurohypophyseal peptide function during early postoperative diabetes insipidus. Brain 1987; 110: 737–746.
Lindsay RS, Seckl JR, Padfield PL. The triple phase response-problems of water balance after pituitary surgery. Postgrad Med J 1995; 71: 439–441.
Robertson GL. Disorders of thirst in man. In: Ramsay DJ, Booth DA, eds. Thirst: Physiological and Psychological Aspects. Springer-Verlag, New York, 1991, pp. 453–475.
Phillips PA, Phil D, Rolls BJ, Ledingahm JGG, Forsling ML, Morton JJ, Crowe MJ, Wollner L. Reduced thirst after water deprivation in healthy elderly men. NEJM 1984; 311: 753–759.
Robertson GL. Abnormalities of thirst regulation. Kidney Internat 1984; 25: 460–469.
Perez GO, Ostre JR, Robertson GL. Severe hypernatremia with impaired thirst. Am J Nephrol 1989; 9: 421–434.
Nandi M, Harrington AR. Succesful treatment of hypernatremic thirst deficiency with chlorpropamide. Clin Nephrol 1978; 10: 90–95.
Vokes TJ, Gaskill MB, Robertson GL. Antibodies to vasopressin in patients with diabetes insipidus. Ann Inter Med 1988; 108: 190–195.
Iwasacki Y, Oiso Y, Kondo K, et al. Aggravation of subclinical diabetes insipidus during pregnancy. N Engl J Med 1991; 324: 522–526.
Durr JA, Hoggard JG, Hunt JM, Schrier RW. Diabetes insipidus in pregnancy associated with abnormally high circulating vasopressinase activity. N Engl J Med 1987; 316: 1070–1074.
Lindheimer MD, Davison JM. Osmoregulation, the secretion of arginine vasopressin and its metabolism during pregnancy. Eur J Endocrinol 1995; 132: 133–143.
Kallen BAJ, Carlsson SS, Bengtsson BKA. Diabetes insipidus and use of desmopressin (Minirin®) during pregnancy. Eur J Endocrinol 1995; 132: 144–146.
Kinsley BT, Swift M, Dumont RH, Swift RG. Morbidity and mortality in the Wolfram syndrome. Diabetes Care 1995; 18: 1566–1570.
Barett TG, Bundey SE. Wolfram (DIDMOAD) syndrome. J Med Genet 1997;34:838–841.
Karasik A, O’Hara C, Sriknata S, et al. Genetically Programmed Selective Islet 13-cell loss in diabetic subjects with Wolfram’s syndrome. Diabetes Care 1989; 12: 135–138.
Thompson CJ, Charlton SW, Walford S, et al. Vasopresson secretion in the DIDMOAD (Wolfram) syndrome. QJM 1989; 71: 333–345.
Alon U, Chan JCM. Hydrochlorothiazide-amiloride in the treatment of congenital nephrogenic diabetes insipidus. Am J Nephrol 1985; 5: 9–13.
Battle DC, von Riotte AB, Gaviria M, Grupp M. Amelioration of polyuria by amiloride in patients receiving long-term lithium therapy. N Engl J Med 1985; 312: 408–414.
Libber S, Harrison H, Spector D. Treatment of nephrogenic diabetes insipidus with prostaglandin synthesis inhibitors. J Pediatr 1986; 108: 305–311.
Jakobsson B, Berg U. Effect of hydrochlorothiazide and indomethacin treatment on ranal function in nephrogenic diabetes insipidus. Acta Pediatr 1994; 83: 522–525.
Monn E. Prostaglandin synthetase inhibitors in the treatment of nephrogenic diabetes insipidus. Acta Pediatr Scand 1981; 70: 39–42.
Allen HM, Jackson RL, Winchester MD, Deck LV, Allon M. Indomethacin in the treatment of lithium-induced nephrogenic diabetes insipidus. Arch Intern Med 1989; 149: 1123–1126.
Monnens L, Jonkman A, Thomas C. Response to indomethacin and hydrochlorothiazide in nephrogenic diabetes insipidus. Clin Sci 1984; 66: 709–715.
Boton R, Gaviria M, Battle DC. Prevalence, pathogenesis and treatment of renal dysfunction associated with chronic lithium therapy. Am J Kidney Dis 1987; 1O (5): 329–345.
Himmelhoch JM, Forrest J, Neil JF, Detre TP. Thiazide-lithium synergy in refractory mood swings. Am J Psychiatry 1977; 134: 149–152.
Hariprasad MK, Eisinger RP, et al. Hyponatremia in psychogenic polydipsia. Arch Intern Med 1980; 140: 1639–1642.
Siegler El, Tamres D, Berlin JA, et al. Risk factors for the development of hyponatremia in psychiatric inpatients. Arch Intern Med 1995; 155: 953–957.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1999 Springer Science+Business Media New York
About this chapter
Cite this chapter
Drincic, A.T., Robertson, G.L. (1999). Treatment of Diabetes Insipidus in Adults. In: Meikle, A.W. (eds) Hormone Replacement Therapy. Contemporary Endocrinology, vol 13. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-700-0_2
Download citation
DOI: https://doi.org/10.1007/978-1-59259-700-0_2
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-61737-092-2
Online ISBN: 978-1-59259-700-0
eBook Packages: Springer Book Archive